Alembic launches generic Xylocaine
Alembic Pharmaceuticals is launching lidocaine, 5% ointment.
The product is the generic of Pfizer’s Xylocaine.
Lidocaine is indicated for production of anesthesia of accessible mucous membranes of the oropharynx. It is also useful as an anesthetic lubricant for intubation and for the temporary relief of pain associated with minor burns, including sunburn, abrasions of the skin, and insect bites.
Alembic will offer lidocaine ointment 5% in 30-g and 35.4-g laminate tubes with a child-resistant cap and a 50-g jar with a child-resistant cap.
No comments found